Procurement of Essential Pharmaceutical Supplies for the Ministry of Defence

Work Description - NA

The Department of Military Affairs, under the Ministry of Defence, is inviting bids for a comprehensive procurement of essential pharmaceutical supplies. This tender, identified by Bid Number GEM/2026/B/7863432, represents an opportunity to supply a diverse range of medications totaling 210,730 units. The bidding period commences on August 1, 2026, at 11:11 AM and concludes on August 22, 2026, at 12:00 PM. The critical item categories encompassed within this solicitation include, but are not limited to, Gliclazide XR 60mg Tablets, Fenofibrate 200mg Tablets, Digoxin 0.25mg Tablets, Ramipril 10mg Tablets, Rivaroxaban 10mg Tablets, Pancreatic Enzyme Supplements with a Lipase content of 25,000 units or more, Trypsin plus Chymotrypsin 100,000 IU Tablets, Thyroxine 50mcg Tablets, Flurbiprofen Sodium 0.03% Eye Drops, Clotrimazole 1% w/v plus Lignocaine 2% w/v Ear Drops (10ml bottle), Nortriptyline 25mg Tablets, Olanzapine 5mg Tablets, Multi-Vitamin Injectables (2-10ml) with specific B1, B6, and B12 constituents, Zidovudine 300mg plus Lamivudine 150mg Tablets, Ranolazine 500mg Tablets, Tetanus Toxoid 0.5ml Injectables, Leflunomide 20mg Tablets, Amoxycillin 875mg plus Clavulanic Acid 125mg Tablets, Capecitabine 500mg Tablets, and Xylometazoline HCl 0.1% Nasal Drops (10ml bottle). This significant procurement underscores the Indian Army's commitment to maintaining robust healthcare services through the timely acquisition of critical pharmaceuticals.